DRG Team

CEO/Geschäftsführer
Dr. Cyril E. Geacintov

Dr. Cyril E. Geacintov is CEO and President of DRG International, Inc., and DRG Subsidiaries overseas. With an innovative vision for manufacturing and distributing critical medical and diagnostics products across the globe, Dr. Geacintov founded DRG in 1970.

Prior to founding DRG, Dr. Geacintov's earlier career included positions as: Vice President at the financial service company Octagon Industries; Manager of Corporate Planning at Celanese; Research Scientist at Mobil; and Adjunct Professor at the Graduate School, Newark College of Engineering. Additionally, Dr. Geacintov served as Director of Avon Products' Export Operations to more than 120 foreign markets.

With a rich understanding of government affairs and global economics, Dr. Geacintov was appointed as Deputy Assistant Secretary of Commerce in Washington, DC in 1974, and as Director of the Bureau of East/West Trade.

Among his professional associations, Dr. Geacintov serves on the board of Directors of the Council for Trade & Economic Cooperation, Inc. (CTEC). He is a member of the Society of Nuclear Medicine and the American Association of Clinical Chemistry.

Dr. Geacintov received his early education in France and Austria. He holds a B.S. Degree (1958) in Paper Science and Engineering and a Ph.D. in Physical Chemistry (1962) from both the State University of New York (SUNY) AND Syracuse University.

Vice President
Elke Geacintov

Elke Geacintov is the Executive Vice President of Administration for DRG International, Inc. and the company's subsidiaries overseas. Reporting directly to the President, Mrs. Geacintov is responsible for the growing implementation needs of DRG International. Her focus is overseeing the growing cooperation in financial and reporting procedures between the United States, and DRG's subsidiaries in Germany, Poland, Russia, Czech Republic and China.

Geschäftsführer/ General Manager
Wilhelm Sänger

Wilhelm Sänger is General Manager of DRG Instruments GmbH in Marburg, Germany.

A part of DRG for nearly 25 years, Mr. Sänger is responsible for finance and administration as well as for the research and development process and also for the manufacturing and production of ELISA diagnostic tests at the facility in Marburg.

In addition, Mr. Sänger is responsible for coordinating the design of a new multi-parameter diagnostic reader, the DRG:HYBRiD.XL. Working in concert with the accompanying unique design and implementation of a proprietary testing procedure, Mr. Sänger is also responsible for the coordination of technical specialists in Europe and the United States.

Prokurist / Regulatory Affairs
Dr. Bernd Röder

Dr. Bernd Röder is the Head of Quality Control for DRG Instruments GmbH located in Marburg, Germany. Dr. Röder has been an integral member of DRG Instruments since early 1990.

With deep involvement in Diplom-Biologist work, Dr. Röder was appointed to Head of Quality control for DRG in 1990. In addition to his Quality Control oversight, he is responsible for Regulatory Affairs.

In 1992, Dr. Röder was granted the Procura ("Authorized Officer"). Since that time, he has been a keystone in the management of DRG Instruments GmbH, and continues to take responsible for recruitment and personnel policy.

Prior to his work with DRG, DR Roeder was involved in research and development in the pharmaceutical industry. The main focus of Dr. Röder's research was in the microbial fermentation process for steroid transformation. Additionally, the subject of his doctoral thesis was in the determination of antibiotic resistance and antibiotic productivity in microorganisms which produce antibiotics.

Entwicklungsleiter/ Head of Research and Development
Dr. Alfred Janetzko

Dr. Alfred Janetzko is the Director of Research and Development for DRG Instruments GmbH located in Marburg, Germany. With approximately 30 years of scientific research and development expertise, Dr. Janetzko has helped lead DRG's product innovation initiatives since 1997.

Dr. Janetzko was a Scientific Assistant at Max-Planck-Institute of cell biology in Ladenburg/ Heidelberg. In this role, he had a special interest in the DNA induced transport of filament proteins in the cell nucleus. During this time, he worked collaboratively with scientists of the German Cancer Research Center to perform Electron-microscopic analysis of HIV infected human cells.

Earlier Dr. Janetzko served as a post-doctoral student and instructor in pharmacology at the Medical Center of New York University, where he performed several studies on localization of glyco-conjugates in developing rat brain in electromotor system of the electric ray torpedo marmorata.

Produktionsleiter/ Head of Production
Dr. Hero Brahms

Dr. Hero Brahms is the Head of Production for DRG Instruments GmbH.

In 2002, Dr. Brahms joined the DRG Group as a Developer in the German facility. An integral part of the research and development team of DRG Instruments, he was involved in the development and validation of new ELISAs. Along with his work in research and development, he is the Medical Security Manager of DRG Instruments.

Earlier in his career, Dr. Brahms worked in the field of Oligonucleotide synthesis at the Max-Planck-Institute for Experimental Medicine in Göttingen, Germany.

Dr. Brahms performed research as a postdoctoral scientist, both in immunology and molecular biology. His work on the role of posttranslational modifications in autoimmune diseases and cell biology at the Max-Planck-Institute for Biophysical Chemistry was awarded with the RPI/ RNA award for young scientists by the RNA Society, which is dedicated to the study of Ribonucleic Acid.

Senior Scientist
Dr. Matthias Herkert

Dr. Herkert is the Senior Scientist in the research and development department of DRG Instruments GmbH.

At DRG, Dr. Herkert is responsible for development of new ELISA kits. He also oversees collaboration with project partners, including university hospitals and research groups. In addition, Dr. Herkert represents DRG in National and International Congresses.

With approximately 20 years of experience at leading institutions, Dr. Herkert has a strong theoretical and practical knowledge in the fields of biochemistry and neuroscience, as well as ELISA assay development.

Before joining DRG Instruments, Dr. Herkert worked at the MTM Laboratories AG. In this role, he was appointed as the Head of Assay Development for Germany. His focus was primarily on development and early detection of cervical cancer.

Head of R&D and Production Infectious Diseases
Ms. Tatiana Wehde

Finanzbuchhaltung/ Finance and Accounting Dept.
Mr. Oswald Krämer

Product Management ELISA / DRG:HYBRiD.XL
Ms. Julia Räder

Product Management Infectious Diseases
Ms. Stefanie Lamers

International Sales
Ms. Petra Baldreich

Marketing & Sales Germany
Ms. Tanja Bräutigam

Verkaufsleiter Deutschland/ Sales Manager Germany
Mr. Armin Haufler

Auftragsbearbeitung/ Order Dept.
Ms. Birgit Ammenhäuser
Ms. Yvonne Leinweber
Ms. Nadine Aillaud

Versand/ Shipping Dept.
Mr. Volker Laucht